Ring Free Gingival Techniqea (NCT07204717) | Clinical Trial Compass
CompletedNot Applicable
Ring Free Gingival Techniqea
Turkey (Türkiye)38 participantsStarted 2018-10-21
Plain-language summary
Objective Peri-implant keratinized mucosa deficiency is a significant factor affecting implant success. Therefore, it is crucial to choose a suitable technique for increasing the width of the keratinized mucosa. This study aims to compare two different approaches of free gingival graft (FGG) application in the treatment of insufficient peri-implant keratinized mucosa and to determine the most effective and predictable technique.
Materials and Methods A total of 38 systemically healthy patients with ≤2 mm of keratinized mucosa in the mandibular anterior region (teeth 33-43) and 38 dental implants were included. Patients were randomly assigned to two groups: Test ( Ring FGG) and Control (Conventional FGG). Clinical parameters including Bleeding on Probing (BOP), Gingival Index (GI), Plaque Index (PI), Probing Depth (PD), Width of Keratinized Mucosa (KMW), Peri-implant Mucosal Thickness (PMT), and Graft Surface Area (GSA) were recorded at baseline, and at 1, 3, and 12 months postoperatively.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. Systemically healthy individuals 2. Age over 18 years 3. Non-smokers 4. No antibiotic therapy for any reason in the past 6 months 5. No previous soft tissue surgery performed in the region of interest 6. KMW≤ 2 mm 7. Presence of inadequate keratinized tissue in the vestibular and/or lingual area of the anterior mandibular implant region 8. Mentally competent to understand the study purpose and procedures explained both verbally and in writing
Exclusion Criteria:
\- 1. Presence of peri-implantitis in the implant(s) planned for FGG application (defined as probing depth ≥ 5 mm, pus discharge, mobility, or severe bone loss) 2. Inability to maintain oral hygiene or presence of implant body and/or abutment fractures in the related region 3. Presence of pathological conditions in the palate that prevent harvesting of a free gingival graft 4. History of systemic diseases such as Diabetes Mellitus, Chronic Renal Failure, Cancer, Bleeding Disorders, Connective Tissue Diseases, etc.
5\. Use of anticoagulant and/or antiplatelet medications
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.